| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.38 | 0.06 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |